Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
Top Cited Papers
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 120 (9) , 1860-1870
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular DegenerationOphthalmology, 2013
- Optical Coherence Tomography Grading Reproducibility during the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2012
- Photographic Assessment of Baseline Fundus Morphologic Features in the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2012
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationOphthalmology, 2012
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Angiographic and Optical Coherence Tomographic Results of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- A computerized method of visual acuity testingAmerican Journal of Ophthalmology, 2003
- Robust Locally Weighted Regression and Smoothing ScatterplotsJournal of the American Statistical Association, 1979